538314-91-9 Usage
Heterocyclic organic compound
Yes
It contains a triazine ring, which is a heterocyclic ring consisting of three nitrogen atoms and three carbon atoms.
Triazine ring
Present
The core structure of the compound is a triazine ring, which is a six-membered ring with alternating nitrogen and carbon atoms.
Substituents
4-methoxyphenyl and methylthio
The triazine ring has two substituents
a 4-methoxyphenyl group and a methylthio group.
Potential applications
Pharmaceuticals, agrochemicals, and materials science
Due to its unique structure and properties, 1,2,4-Triazin-5(2H)-one, 6-(4-methoxyphenyl)-3-(methylthio)- may be used in the development of new drugs, synthesis of novel materials, and other specialized chemical products.
Biological activities
Potential for further research and development
The compound may have biological activities that are of interest for further research and development, which could lead to new applications in various fields.
Structure
Unique arrangement of atoms and functional groups
The specific arrangement of atoms and functional groups in 1,2,4-Triazin-5(2H)-one, 6-(4-methoxyphenyl)-3-(methylthio)- contributes to its potential applications and properties.
Check Digit Verification of cas no
The CAS Registry Mumber 538314-91-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,3,8,3,1 and 4 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 538314-91:
(8*5)+(7*3)+(6*8)+(5*3)+(4*1)+(3*4)+(2*9)+(1*1)=159
159 % 10 = 9
So 538314-91-9 is a valid CAS Registry Number.
538314-91-9Relevant academic research and scientific papers
3-ARYL-6-ARYL-7H-[1,2,4]TRIAZOLO[3,4-b][1,3,4]THIADIAZINES AND ANALOGS AS ACTIVATORS OF CASPASES AND INDUCERS OF APOPTOSIS AND THE USE THEREOF
-
Page/Page column 36, 71-72, (2008/06/13)
Disclosed are 3-aryl-6-aryl-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and analogs thereof, represented by the Formula (I), wherein Ar1, Q2, R1, R2, dashed line and X are defined herein. The present invention relates to the discovery that compounds having Formula (I) are activators of caspases and inducers of apoptosis. Therefore, the activators of caspases and inducers of apoptosis of this invention may be used to induce cell death in a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs.
